Last reviewed · How we verify
Treatment-Resistant Schizophrenia
Approved treatments
- Clozaril · Jazz Pharmaceuticals
Clozapine's efficacy in schizophrenia may be due to its antagonism of D2 and 5-HT2A receptors. - Clozaril · Dong Wha Pharmaceutical Co. Ltd.
- Fazaclo · Manhattan Psychiatric Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Treatment-Resistant Schizophrenia patent landscape — cliff calendar, originator estates, attackable patents
- Treatment-Resistant Schizophrenia treatment landscape brief
- Treatment-Resistant Schizophrenia treatment updates RSS
Frequently asked questions about Treatment-Resistant Schizophrenia
What drugs treat Treatment-Resistant Schizophrenia?
Tracked treatments include Clozaril, Fazaclo.
What is the treatment for Treatment-Resistant Schizophrenia?
Standard treatment for Treatment-Resistant Schizophrenia includes Clozaril, Fazaclo. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Treatment-Resistant Schizophrenia patent cliff · Treatment-Resistant Schizophrenia CI report
- Treatment: Clozaril · Jazz Pharmaceuticals
- Treatment: Clozaril · Dong Wha Pharmaceutical Co. Ltd.
- Treatment: Fazaclo · Manhattan Psychiatric Center
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing